Join the club for FREE to access the whole archive and other member benefits.

Eligo Bioscience

Synthetic Biology company for targeted antimicrobials and microbiome editing.

Eligo Bioscience was created in 2014 based on the research from the Lu Lab (MIT) and the Marraffini Lab (Rockefeller University), which was later published in Nature Biotechnology. 

Eligo was incubated at the Institut Pasteur in Paris from 2014 to 2017 and has moved in 2017 into the biotech cluster “Paris Biotech Santé” in the Cochin Hospital.. 

Visit website:




People at Eligo Bioscience

Xavier Duportet

CEO at Eligo Bioscience.

Eligo Bioscience News

Synthetic Nanobots Could End Antibiotic Resistance

Futurism - 17-Nov-2017

Most current antibiotics wipe out all bacteria - good and bad. French startup Eligo Bioscience i...


Funding to build biological nanorobots

Silicon Republic - 28-Sep-2017

Founded in 2014, France-based Eligo Bioscience has received $20m Series A funding. Aims is to tr...